Where is the FDA test for relapsing fever spirochete, Borrelia miyamotoi?

If the FDA gets its way, physicians would only have access to diagnostic tests for tick borne diseases that are FDA approved.  This would eliminate “specialty labs,” and severely restrict a clinicians ability to diagnose Lyme disease, as well as other tick-borne co-infections. This is a dangerous move in a period when we’re seeing an […]

Where is the FDA test for relapsing fever spirochete, Borrelia miyamotoi? Read More »